EMJ Hematology 10 [Supplement 2] . 2022

In this issue

EXPERT discussion from a satellite symposium presented at the European Hematology Association (EHA) Virtual Congress 2021 focused on myelodysplastic syndrome (MDS), a heterogeneous group of myeloid malignancies characterised by ineffective haematopoiesis, progressive bone marrow failure, and increased risk of acute myeloid leukaemia evolution.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.